The abstract is read at the publisher; the summary is JClub's.
Neural stem cell gene therapy using iPSC-derived SGSH-transduced progenitors in NSG-MPSIIIA mice fully corrected spatial working memory deficits and reduced brain heparan sulfate storage.
- Why it matters: MPS IIIA lacks disease-modifying treatments because existing methods do not deliver enough enzyme to the brain or stop neurodegeneration.
- What they did: Healthy and MPS IIIA patient fibroblasts were reprogrammed to iPSCs, differentiated into neural progenitors, and transduced with lentiviral vectors encoding codon-optimized SGSH and luciferase before bilateral striatal transplantation at 2 months of age.
- The result: At 3 months after injection, behavioral and histological analyses showed full spatial working memory correction alongside significant decreases in heparan sulfate storage and astrogliosis, supporting broad therapeutic potential for lysosomal storage disorders.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.